Literature DB >> 28301267

Hypotonic-hyporesponsive episodes after administration of hexavalent DTP-based combination vaccine: A description of 12 cases.

Alessandro Vigo1, Giulia Costagliola1, Elisa Ferrero1, Silvia Noce1.   

Abstract

Hypotonic-hyporesponsive (HHE) episodes are known and recognized phenomena, which typically occur within 48 hours of immunisation..Our aim is to describe 12 cases of HHE brought to the Center of Pediatric Sleep Medicine, with attention to the clinical features of the episode and their follow-up. Medical charts of infants visited between 2005-2015 were reviewed. Twelve infants showed a HHE using HHE using Brighton Collaboration Criteria. All infants received a Hexavalent diphtheria -tetanus -pertussis acellular component -hepatitis B-,inactivated poliovirus- Haemophilus influenzae type-b conjugate vaccine. Five out of 12 were brought to Emergency Department, where 2 were symptomatic (one was hyporeactive, the other had fever). No infant died during the episode, or the follow-up, nor developed neurological disease after subsequent vaccinations. HHE are confirmed as benign events, even after administration of hexavalent vaccination, devoid of negative neuropsychomotor outcome.

Entities:  

Keywords:  HHE; emergency department; hexavalent; infant; vaccination; vagal reaction

Mesh:

Substances:

Year:  2017        PMID: 28301267      PMCID: PMC5489273          DOI: 10.1080/21645515.2017.1287642

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  14 in total

Review 1.  Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.

Authors:  S Michael Marcy; Katrin S Kohl; Ron Dagan; David Nalin; Michael Blum; Marcy Connell Jones; John Hansen; Jerry Labadie; Lucia Lee; Bryan L Martin; Katherine O'Brien; Edward Rothstein; Patricia Vermeer
Journal:  Vaccine       Date:  2004-01-26       Impact factor: 3.641

2.  Hypotonic hyporesponsive episode and the 13-valent pneumococcal vaccine.

Authors:  Lampros Fotis; Andriani Vazeou; Maria Xatzipsalti; Lela Stamoyannou
Journal:  Turk J Pediatr       Date:  2014 Jul-Aug       Impact factor: 0.552

Review 3.  The Involvement of Parasympathetic and Sympathetic Nerve in the Inflammatory Reflex.

Authors:  Mariana Rodrigues Pereira; Paulo Emílio Corrêa Leite
Journal:  J Cell Physiol       Date:  2016-02-02       Impact factor: 6.384

Review 4.  Paroxysmal vagal overactivity, apparent life-threatening event and sudden infant death.

Authors:  V Lucet; O de Bethmann; I Denjoy
Journal:  Biol Neonate       Date:  2000-07

5.  Hypotonic-hyporesponsive episode in a 7-month-old infant after receipt of multiple vaccinations.

Authors:  Paul McPherson; Keith R Powell
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

6.  Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998.

Authors:  T S DuVernoy; M M Braun
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

7.  Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization.

Authors:  M M Braun; G Terracciano; M E Salive; D A Blumberg; P E Vermeer-de Bondt; H Heijbel; G Evans; P A Patriarca; S S Ellenberg
Journal:  Pediatrics       Date:  1998-11       Impact factor: 7.124

Review 8.  Recommended clinical evaluation of infants with an apparent life-threatening event. Consensus document of the European Society for the Study and Prevention of Infant Death, 2003.

Authors:  André Kahn
Journal:  Eur J Pediatr       Date:  2003-12-03       Impact factor: 3.183

9.  Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program.

Authors:  Reinaldo M Martins; Luiz A B Camacho; Maria Cristina F Lemos; Tatiana G de Noronha; Maria Helena C de Carvalho; Nadja Greffe; Marli M da Silva; André R Périssé; Maria Lourdes S Maia; Akira Homma
Journal:  J Pediatr (Rio J)       Date:  2007 Nov-Dec       Impact factor: 2.197

Review 10.  Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials.

Authors:  Merryn Voysey; Andrew J Pollard; Rafael Perera; Thomas R Fanshawe
Journal:  BMJ Open       Date:  2016-07-29       Impact factor: 2.692

View more
  5 in total

Review 1.  [Postvaccinal complications and management of suspected cases].

Authors:  Doris Oberle; Dirk Mentzer; Fabia Rocha; Renz Streit; Karin Weißer; Brigitte Keller-Stanislawski
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

2.  [Recommendations on the approach when unusual neurological symptoms occur in temporal association with vaccinations in childhood and adolescence].

Authors:  Hans-Iko Huppertz
Journal:  Monatsschr Kinderheilkd       Date:  2020-07-21       Impact factor: 0.323

3.  Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru.

Authors:  Janice Seinfeld; María Laura Rosales; Alfredo Sobrevilla; Juan Guillermo López Yescas
Journal:  BMC Health Serv Res       Date:  2022-05-16       Impact factor: 2.908

4.  Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014-19.

Authors:  Pasquale Stefanizzi; Francesco Paolo Bianchi; Giuseppe Spinelli; Fabio Amoruso; Domenica Ancona; Paolo Stella; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2021-08-26       Impact factor: 3.452

5.  Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017.

Authors:  Pasquale Stefanizzi; Sara De Nitto; Francesco Patano; Francesco Paolo Bianchi; Davide Ferorelli; Paolo Stella; Domenica Ancona; Vito Bavaro; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2020-02-10       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.